论文部分内容阅读
目的了解同型半胱氨酸(homocysteine,Hcy)在慢性肝炎患者中的变化及意义。方法回顾分析我院住院127例慢性肝病患者临床资料,其中慢性乙肝61例、肝硬化47例、肝癌19例,检测患者血浆同型半胱氨酸水平,同对照组58例健康人的血浆同型半胱氨酸进行比较。结果慢性肝病患者同型半胱氨酸水平明显升高,相对于对照组有统计学意义(<0.05),如果以同型半胱氨酸单一指标做标准对慢性肝炎的检出率高达90.6%。结论血浆同型半胱氨酸对慢性肝炎关系密切,可以作为检测、监测慢性肝病发生、发展的一个参考指标。“,”Objective To investigate the homocysteine (homocysteine, Hcy) Changes and significance in patients with chronic hepatitis. Methods Retrospective analysis of our hospital 127 cases of clinical data in patients with chronic liver disease, including chronic hepatitis B 61 cases, 47 cases of liver cir hosis, liver cancer 19 cases, plasma homocysteine concentration in patients with the control group58 cases of healthy individuals, plasma homocysteine were compared. Results Patients with chronic liver disease homocysteine levels were significantly increased, compared with the control group was statistical y significant ( <0.05), if homocysteine single index as the standard for chronic hepatitis detection rate of 90.6% .Conclusion Plasma homocysteine closely for chronic hepatitis, can be used as the detection and monitoring of chronic liver disease, the development of a reference index.